Company Quick10K Filing
Artelo Biosciences
10-Q 2020-11-30 Filed 2021-01-14
S-1 2020-09-28 Public Filing
10-K 2020-08-31 Filed 2020-11-04
10-Q 2020-05-31 Filed 2020-07-13
10-Q 2020-02-29 Filed 2020-04-13
10-Q 2019-11-30 Filed 2020-01-14
10-K 2019-08-31 Filed 2019-11-25
10-Q 2019-05-31 Filed 2019-07-15
S-1 2019-04-01 Public Filing
10-Q 2019-02-28 Filed 2019-04-15
10-Q 2018-11-30 Filed 2019-01-14
S-1 2018-09-27 Public Filing
10-K 2018-08-31 Filed 2018-11-29
10-Q 2018-05-31 Filed 2018-07-13
10-Q 2018-02-28 Filed 2018-04-16
S-1 2018-01-29 Public Filing
10-Q 2017-11-30 Filed 2018-01-16
10-K 2017-08-31 Filed 2017-11-29
10-Q 2017-05-31 Filed 2017-07-21
10-Q 2017-02-28 Filed 2017-04-14
10-Q 2016-11-30 Filed 2017-01-10
10-K 2016-08-31 Filed 2016-11-29
10-Q 2016-05-31 Filed 2016-07-05
10-Q 2016-02-29 Filed 2016-04-01
10-Q 2015-11-30 Filed 2016-01-14
10-K 2015-08-31 Filed 2015-12-11
10-Q 2015-05-31 Filed 2015-07-15
10-Q 2015-02-28 Filed 2015-04-14
8-K 2021-02-16 Other Events
8-K 2021-02-12 Officers
8-K 2020-12-03 Shareholder Vote
8-K 2020-11-30 Officers
8-K 2020-11-17
8-K 2020-10-09
8-K 2020-07-14
8-K 2020-06-22
8-K 2020-06-19
8-K 2020-04-13
8-K 2020-03-06
8-K 2020-02-05
8-K 2020-01-14
8-K 2019-12-02
8-K 2019-11-14
8-K 2019-08-30
8-K 2019-07-15
8-K 2019-06-21
8-K 2019-04-24
8-K 2019-03-06
8-K 2019-03-01
8-K 2018-10-09
8-K 2018-09-12
8-K 2018-05-30
8-K 2018-01-26
8-K 2018-01-18

Artelo Biosciences Financials

ARTL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS) 40,869 77% -17.5 -11% 226,103 289,374 72,620 55,706 -24,956 -13,928 243,484
Clovis Oncology (CLVS) 219,222 0% -0.0 -56% 716,892 804,387 134,050 0 -400,184 -394,255 17,741
Cementos Pacasmayo Saa (CPAC) 4,145,433 0% 2,863,245 1,411,882 0 0 0 0 4,145,433
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ) 122,881 1.0 0% 961,684 868,577 0 0 3,422 14,772 14,360
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash813174444411228573412525326337115457286
Accounts Receivable
Inventory
PP&E1111001
Assets8131744444132285744305414013971654841,153
Accounts Payable
Long-Term Debt
Liabilities2023813171033342291361564925326411,1761,019
Stockholders' Equity713151-4-9-14-6-19-114545294385-91-135-475-692134
Income Statement ($'000)2015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue0000000000
Cost of Revenue
Gross Profit
R&D33477237332184490184
SG&A0111000418861373110523620658403
Tax000000000000000000
Net Income-6-2-5-15-5-5-4-10-13-97-116-277-628-578-690-557-425-345
Cash Flow ($'000)2015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating-4-3-14-0-400-22-37-158-170-467-459-514-401-741-589
Cash Investing00000-1-00
Cash Financing71040030254502115812705261741,087419